NM_004044.7:c.147-111A>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004044.7(ATIC):​c.147-111A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 1 in 940,902 control chromosomes in the GnomAD database, including 470,382 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 1.0 ( 76134 hom., cov: 33)
Exomes 𝑓: 1.0 ( 394248 hom. )

Consequence

ATIC
NM_004044.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.985

Publications

4 publications found
Variant links:
Genes affected
ATIC (HGNC:794): (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009]
ATIC Gene-Disease associations (from GenCC):
  • AICA-ribosiduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 2-215318046-A-T is Benign according to our data. Variant chr2-215318046-A-T is described in ClinVar as [Benign]. Clinvar id is 1192367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATICNM_004044.7 linkc.147-111A>T intron_variant Intron 2 of 15 ENST00000236959.14 NP_004035.2 P31939-1V9HWH7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATICENST00000236959.14 linkc.147-111A>T intron_variant Intron 2 of 15 1 NM_004044.7 ENSP00000236959.9 P31939-1

Frequencies

GnomAD3 genomes
AF:
1.00
AC:
152194
AN:
152232
Hom.:
76078
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.999
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
1.00
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
1.00
GnomAD4 exome
AF:
1.00
AC:
788524
AN:
788552
Hom.:
394248
AF XY:
1.00
AC XY:
412724
AN XY:
412742
show subpopulations
African (AFR)
AF:
0.999
AC:
19708
AN:
19726
American (AMR)
AF:
1.00
AC:
39635
AN:
39638
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
21586
AN:
21586
East Asian (EAS)
AF:
1.00
AC:
35148
AN:
35148
South Asian (SAS)
AF:
1.00
AC:
68385
AN:
68386
European-Finnish (FIN)
AF:
1.00
AC:
49841
AN:
49842
Middle Eastern (MID)
AF:
1.00
AC:
4424
AN:
4424
European-Non Finnish (NFE)
AF:
1.00
AC:
511907
AN:
511908
Other (OTH)
AF:
1.00
AC:
37890
AN:
37894
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6122
12244
18366
24488
30610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
1.00
AC:
152309
AN:
152350
Hom.:
76134
Cov.:
33
AF XY:
1.00
AC XY:
74486
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.999
AC:
41537
AN:
41576
American (AMR)
AF:
1.00
AC:
15290
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5192
AN:
5192
South Asian (SAS)
AF:
1.00
AC:
4832
AN:
4832
European-Finnish (FIN)
AF:
1.00
AC:
10620
AN:
10620
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68046
AN:
68046
Other (OTH)
AF:
1.00
AC:
2114
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
1.00
Hom.:
9294
Bravo
AF:
1.00
Asia WGS
AF:
0.999
AC:
3473
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

AICA-ribosiduria Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.91
DANN
Benign
0.23
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4672766; hg19: chr2-216182769; API